Intracrine androgens and AKR1C3 activation confer resistance to enzalutamide in prostate cancer

類似資料

• Niclosamide inhibits androgen receptor variants expression and overcomes enzalutamide resistance in castration resistant prostate cancer
  著者:: Liu, Chengfei, 等
  出版事項: (2014)
• NF-κB2/p52 Induces Resistance to Enzalutamide in Prostate Cancer: Role of Androgen Receptor and Its Variants
  著者:: Nadiminty, Nagalakshmi, 等
  出版事項: (2013)
• RhoGDIα Downregulates Androgen Receptor Signaling in Prostate Cancer Cells
  著者:: Zhu, Yezi, 等
  出版事項: (2013)
• NF-kappaB2/p52:c-Myc:hnRNPA1 pathway regulates expression of androgen receptor splice variants and enzalutamide sensitivity in prostate cancer
  著者:: Nadiminty, Nagalakshmi, 等
  出版事項: (2015)
• Andrographolide Targets Androgen Receptor Pathway in Castration-Resistant Prostate Cancer
  著者:: Liu, Chengfei, 等
  出版事項: (2011)